Alpha-synuclein as a therapeutic target for Parkinson’s disease: challenges and opportunities

  Рет қаралды 7,427

Stanford APDA

Stanford APDA

Күн бұрын

Пікірлер: 5
@zhuzhou
@zhuzhou Жыл бұрын
BTW Ambroxol, while OTC in Europe, is not FDA approved in the united states.
@douglaswatt1582
@douglaswatt1582 7 ай бұрын
It's still amazes me when senior people who should know better talk about aggregated proteins in neurodegenerative disorders as simple causes instead of markers or as causes in interaction. Contrary to the overconfident protein-centric view of neurodegenerative disorders, we actually don't understand what's causing them. And to describe aggregated protein is the cause obscures the simple fact that we don't know where these protein aggregates really come from or how they get started or how they escaped protein quality control, in other words the failure of proteostasis has to be antecedent to these aggregates spreading. In addition, the aggregates aren't simply a cause of inflammation they are often times spread via inflammation and changes in the glial system, famously the Tauopathy in Alzheimer's disease. Additionally there are over two dozen monoclonal antibody therapies that have failed to show disease modification or that show only very minimal slowing of degeneration despite the success that these oftentimes have in removing the protein villain. So this whole proteinopathic theory of neurodegeneration has serious challenges and even more serious holes in it. This is not to suggest the ridiculous notion that protein aggregates are not contributing to neurodegeneration, because that's also ridiculous. But it is not by any conceivable stretch a complete theory of neurodegeneration and far from a guide to treating clinical stage disease.
@robertbernard651
@robertbernard651 Жыл бұрын
What can we do to help this process?
@ottoavila9895
@ottoavila9895 2 жыл бұрын
Can ll-37 inhibit alpha-synuclein?
@supremoluminary
@supremoluminary 6 ай бұрын
“She received her medical training in Germany and umm uhh later on umm a umm study genetics..” If you can’t speak, don’t. People come to the Internet to get information. We are not captive audience submissively held captive to kiss up to the professor in order to get a grade. As a teacher, as a speaker, you fail.
Updates in Therapeutics for Parkinson’s Disease
56:50
Stanford APDA
Рет қаралды 10 М.
Parkinson's Disease:- Red Light Therapy - Photobiomodulation
58:00
nosilverbullet4pd
Рет қаралды 88 М.
Every parent is like this ❤️💚💚💜💙
00:10
Like Asiya
Рет қаралды 18 МЛН
Please Help This Poor Boy 🙏
00:40
Alan Chikin Chow
Рет қаралды 23 МЛН
Миллионер | 1 - серия
34:31
Million Show
Рет қаралды 2,2 МЛН
Do you choose Inside Out 2 or The Amazing World of Gumball? 🤔
00:19
Robert Sapolsky: The Biology of Humans at Our Best and Worst
1:13:13
Stanford Iranian Studies Program
Рет қаралды 952 М.
APOE TREM and Microglia in the Pathogenesis of Tau-mediated Neurodegeneration with David Holtzman MD
52:06
University of California Television (UCTV)
Рет қаралды 18 М.
Serine-129 Phosphorylation of α-Synuclein
15:16
Neurology Journal
Рет қаралды 167
Diagnosing PSP (Progressive Supranuclear Palsy) | 8-30-17 Webinar
31:25
Webinar: "Primary Parkinson's Protein Alpha-synuclein" November 2016
1:03:21
The Michael J. Fox Foundation for Parkinson's Research
Рет қаралды 12 М.
Health Matters 2023: Food as Medicine - Eat Well for Longevity and Health
52:43
Every parent is like this ❤️💚💚💜💙
00:10
Like Asiya
Рет қаралды 18 МЛН